Financing repurposed drugs for rare diseases: a case study of Unravel Biosciences

Financing repurposed drugs for rare diseases: a case study of Unravel Biosciences

Abstract Background We consider two key challenges that early-stage biotechnology firms face in developing a sustainable financing strategy and a sustainable business model: developing a valuation model for drug compounds, and choosing an appropriate...

Full description

Bibliographic Details
Main Authors: Abouarab, Bechara, Bazarian, Christian, Ben Chaouch, Zied, Lo, Andrew W., Mourenza Gonzalez, Guillermo, Novak, Richard, Vigneault, Frederic
Other Authors: Sloan School of Management
Format: Article
Language:English
Published: BioMed Central 2023
Online Access:https://hdl.handle.net/1721.1/152279

Similar Items

Similar Items